Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-21
2006-02-21
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S212080, C540S524000, C540S527000
Reexamination Certificate
active
07001899
ABSTRACT:
The present invention relates to novel compounds, compositions comprising said compounds, and uses thereof, said compounds having the formula:wherein each X is independently selected from:i) —C(W)2—;ii) —C(O)—;iii) —NR2—;iv) —S—;v) —S(O)—;vi) —S(O)2—;vii) two units, one from each adjacent X unit, can be taken together to form a substituted or unsubstituted double bond having the formula —CW═CW—; wherein each W is hydrogen of a unit having the formula —(L2)j—R2, the index j is 0 or 1;R is a carbocyclic or heterocyclic aryl ring;R1is a cysteine trap;each R2is independently a suitable substituent; andL, L1, and L2are linking units.
REFERENCES:
patent: 5656627 (1997-08-01), Bemis et al.
patent: 5670494 (1997-09-01), Dolle et al.
patent: 5716929 (1998-02-01), Bemis et al.
patent: 5756466 (1998-05-01), Bemis et al.
patent: 5847135 (1998-12-01), Bemis et al.
patent: 5973111 (1999-10-01), Bemis et al.
patent: 6025147 (2000-02-01), Bemis et al.
patent: 6103711 (2000-08-01), Bemis et al.
patent: 6136834 (2000-10-01), Ohmoto et al.
patent: 6162800 (2000-12-01), Dolle et al.
patent: 6329365 (2001-12-01), Golec et al.
patent: 6350741 (2002-02-01), Golec et al.
patent: 6407080 (2002-06-01), Dolle et al.
patent: 0761680 (1997-03-01), None
patent: 10-251295 (1997-09-01), None
patent: WO 99/47545 (1999-09-01), None
Vo-Thanh et al. (Synlett (2001), (1), 37-40) Abstract.
Piscopio et al. (Tetrahedron Letters 39 (1998) 2667-2670).
Piscopio et al. (Tetrahedron 55 (1999) 8189-8198).
Karanewsky, D.S., et al., “Conformationally Constrained Inhibitors of Caspase-10(Interleukin-1β Converting Enzyme) and of the Human CED-3 Homologue Caspase-3 (CPP32, Apopain)”,Bioorganic&Medicinal Chemistry Letters, 1998, vol. 8, No. 19, pp. 2757-2762.
De Biswanath
Demuth, Jr. Thomas Prosser
Laufersweiler Michael Christopher
O'Neil Steven Victor
Oppong Kofi Abeka
Echler Sr. Richard S.
Kifle Bruck
The Procter & Gamble & Company
LandOfFree
Interleukin converting enzyme inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin converting enzyme inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin converting enzyme inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3674809